Re: Stock of the Day- Pfizer (PFE)
A couple of problems I saw at a glance:
1) They're paying nearly 60% of their EPS back as dividends. I think they could be using this money elsewhere in a more productive fashion.
2) P/E is a tad too high.
3) Pharmaceuticals make me nervous because they often rush to get drugs on the market, and we never know what the next Vioxx is going to be.
That said, their FCF growth seems really good, and I'll look at it closer at a later time.
|